[1]
“Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma”, Ann Med Res , vol. 29, no. 3, pp. 198–202, Mar. 2022, Accessed: Oct. 21, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4147